Abstract:Cancer represents one of the conditions with the most causes of death worldwide. Common methods for its diagnosis are based on tissue biopsies-the extraction of tissue from the primary tumor, which is used for its histological analysis. However, this technique represents a risk for the patient, along with being expensive and time-consuming and so it cannot be frequently used to follow the progress of the disease. Liquid biopsy is a new cancer diagnostic alternative, which allows the analysis of the molecular information of the solid tumors via a body fluid draw. This fluid-based diagnostic method displays relevant advantages, including its minimal invasiveness, lower risk, use as often as required, it can be analyzed with the use of microfluidic-based platforms with low consumption of reagent, and it does not require specialized personnel and expensive equipment for the diagnosis. In recent years, the integration of sensors in microfluidics lab-on-a-chip devices was performed for liquid biopsies applications, granting significant advantages in the separation and detection of circulating tumor nucleic acids (ctNAs), circulating tumor cells (CTCs) and exosomes. The improvements in isolation and detection technologies offer increasingly sensitive and selective equipment's, and the integration in microfluidic devices provides a better characterization and analysis of these biomarkers. These fully integrated systems will facilitate the generation of fully automatized platforms at low-cost for compact cancer diagnosis systems at an early stage and for the prediction and prognosis of cancer treatment through the biomarkers for personalized tumor analysis.

Paper-Based Analytical Devices for Cancer Liquid Biopsy

SERS biosensors for liquid biopsy towards cancer diagnosis by detection of various circulating biomarkers: current progress and perspectives

Toward Personalized Nanomedicine: The Critical Evaluation of Micro and Nanodevices for Cancer Biomarker Analysis in Liquid Biopsy

Sensor-Integrated Microfluidic Approaches for Liquid Biopsies Applications in Early Detection of Cancer

Point-of-care cancer diagnostic devices: From academic research to clinical translation

Cancer Liquid Biopsy Using Integrated Microfluidic Exosome Analysis Platforms

Bioplatforms in liquid biopsy: advances in the techniques for isolation, characterization and clinical applications

Surface Plasmon Resonance for Biomarker Detection: Advances in Non-invasive Cancer Diagnosis

Biomarker Detection in Early Diagnosis of Cancer: Recent Achievements in Point-of-Care Devices Based on Paper Microfluidics

Liquid Biopsies, Novel Approaches and Future Directions

The Liquid Biopsy Consortium: Challenges and Opportunities for Early Cancer Detection and Monitoring

Liquid biopsies for cancer: From bench to clinic

Paper-based biosensors as point-of-care diagnostic devices for the detection of cancers: a review of innovative techniques and clinical applications

Paper-Based Materials for Diagnostics

The Use of Microfluidic Technology for Cancer Applications and Liquid Biopsy

Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments

Liquid Biopsy: A Distinctive Approach to the Diagnosis and Prognosis of Cancer

LIQUID BIOPSY: A NON-INVASIVE TOOL TO DETECT CANCER AT AN EARLY STAGE

Liquid biopsies: the future of cancer early detection

Recommendations for the Equitable and Widespread Implementation of Liquid Biopsy for Cancer Care

Recent Progress on Liquid Biopsy Analysis using Surface-Enhanced Raman Spectroscopy